Yasushi Sato

30PUBLICATIONS
38CO-AUTHORS
Medical biochemistry - lipidsCancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jul 28, 2026
Comparing the Effect of Changes in Alcohol Intake on Liver Fibrosis Risk Scores Among Patients With Two Distinct Types of Steatotic Liver Disease.

|Apr 04, 2026
Orthotopic Esophageal Cancer Xenograft Model in Immunosuppressed Microminipigs for Near-Infrared Fluorescence Endoscopy.

Takanori Miyake, Yutaka Kawano, Takanori Kashihara

|Aug 21, 2025
Association of Metabolic-Associated Steatotic Liver Disease With Clinical Outcomes of Durvalumab and Tremelimumab in Advanced Hepatocellular Carcinoma Patients: A Multicenter Study.

Takeshi Hatanaka, Shigeo Shimose, Takanori Ito

|Aug 20, 2025
ROS-Driven PKCζ Signaling as a Widely Involved Mechanism for Cancer Cell Motility and Metastasis.

Yasushi Sato, Maki Tanaka, Naoko Kitamura

|May 28, 2025
A novel approach to evaluate the therapeutic efficacy of durvalumab and tremelimumab combination therapy in hepatocellular carcinoma.

Tetsu Tomonari, Shigeo Shimose, Issei Saeki

|Apr 23, 2025
Conditions for effective use of liposomal irinotecan with fluorouracil and leucovorin in unresectable pancreatic cancer after FOLFIRINOX treatment.

Yasuyuki Okada, Yasushi Sato, Ryo Shinomiya

Pageof 5

Frequent Collaborators

8 joint publications

Tetsuji Takayama

8 joint publications

Hiroshi Miyamoto

6 joint publications

Hironori Tanaka

4 joint publications

Tetsu Tomonari